How can menstruation be stopped in a 12-year-old girl?

Menstrual Suppression in a 12-Year-Old

For a 12-year-old requiring menstrual suppression, combined hormonal contraceptives (pills, patches, or rings) used continuously or extended-cycle are first-line, with levonorgestrel IUDs as an equally effective alternative, particularly when long-acting reversible contraception is desired. 1, 2

Clinical Approach

Initial Considerations

Before initiating therapy, determine the specific indication for menstrual suppression, as this guides method selection:

• Heavy menstrual bleeding causing anemia
• Severe dysmenorrhea
• Menstrual-related disability (physical or developmental)
• Medical conditions complicated by menstruation
• Patient preference for amenorrhea

Critical pitfall: A pelvic examination is NOT required before prescribing contraceptives or hormonal therapy in adolescents 1. This outdated requirement creates unnecessary barriers to care.

Treatment Options (in order of preference)

First-Line: Combined Hormonal Contraceptives

• Continuous or extended-cycle regimens are most effective for complete menstrual suppression 2, 3
• Available as pills, patches, or vaginal rings
• Provide excellent cycle control and treat common comorbidities (acne, dysmenorrhea, heavy bleeding) 1
• Can be initiated immediately without waiting for next menstrual period

First-Line Alternative: Levonorgestrel IUD

• Long-acting reversible contraception (LARC) should be considered first-line given superior efficacy, safety, and ease of use 1
• Achieves amenorrhea in majority of users over time
• Particularly valuable when adherence concerns exist or long-term suppression needed
• Requires referral if you don't place IUDs, but AAP guidelines emphasize pediatricians should identify providers who can 1

Second-Line Options

• Depot medroxyprogesterone acetate (DMPA): Highly effective but has bone density concerns in adolescents—still much safer than pregnancy 1, 2
• Progestin-only pills: Continuous use can achieve amenorrhea
• Norethindrone acetate or oral medroxyprogesterone acetate: Non-contraceptive progestin options 2, 4

Third-Line (Specialist Consultation)

• GnRH agonists: Reserved for specific conditions like endometriosis, require add-back therapy 2, 4

Key Clinical Principles

Counseling Framework

Use a patient-centered, developmentally appropriate approach 1:

• Educate about ALL safe and appropriate methods
• Describe the most effective methods first (LARC, then combined hormones) 1
• Allow adolescent to make informed choice based on preferences
• Schedule separate follow-up visit if needed to ensure adequate time 1

Confidentiality

• Allow the adolescent to consent to contraceptive care within state law limits 1
• Adolescent controls information disclosure to parents (with legal exceptions)
• Be familiar with your state's minor consent laws 1

Safety Considerations

Common misconception: Menstruation is NOT medically necessary 5. Suppression is safe and often improves quality of life 2, 5, 3.

• No method should be withheld based on age alone 4
• Adolescents with chronic illness have similar contraceptive needs as healthy teens, though medical conditions may complicate choices 1
• Combined hormonal methods and DMPA are much safer than pregnancy despite attention to adverse effects 1

Follow-Up

• Frequent follow-up maximizes adherence for all methods 1
• Monitor for adverse effects and complications
• Regularly update sexual history in confidential, nonjudgmental setting 1
• Screen for STIs (chlamydia) without pelvic exam if sexually active 1

Red Flags Requiring Further Evaluation

If menorrhagia is the indication and no response to hormonal therapy within 48 hours, reevaluate for coagulopathy or other hematologic disease 6. Heavy bleeding at menarche warrants excluding underlying bleeding disorders before attributing to anovulation alone.

The evidence strongly supports that multiple effective options exist for menstrual suppression in adolescents, with selection based on clinical indication, medical eligibility, contraceptive needs, and patient preference 2. The 2014 AAP guidelines provide the authoritative framework emphasizing LARC-first approaches and removing barriers like unnecessary pelvic exams 1, while recent 2025 literature confirms multiple hormonal options are effective and safe 2, 5.